CIRCULATION Journal
Circulation is a scientific journal published by Lippincott Williams & Wilkins for the American Heart Association. The journal publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research. Articles become open access after a 12-month embargo period.
Overview
publication venue for
- Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial. 147:1004-1013. 2023
- Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial 2022
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 145:E18-E114. 2022
- Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes 2021
- Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function Observations From VERTIS CV 2021
- A Novel Endocrine Role for the BAT-Released Lipokine 12,13-diHOME to Mediate Cardiac Function. 143:145-159. 2021
- Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. 143:7-17. 2021
- Should Cardiologists Risk-stratify Patients With Atherosclerotic Cardiovascular Disease by Kidney Function? Results From the VERTIS CV Trial Evaluating Efficacy of Ertugliflozin on Cardiovascular and Kidney Outcomes by Baseline Kidney Function 2020
- Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial. 142:2205-2215. 2020
- Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes. 140:1578-1589. 2019
- Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial. 140:103-112. 2019
- Consumption of Meat, Fish, Dairy Products, and Eggs and Risk of Ischemic Heart Disease A Prospective Study of 7198 Incident Cases Among 409 885 Participants in the Pan-European EPIC Cohort. 139:2835-2845. 2019
- A Peculiar Wide Complex Tachycardia (vol 139, pg 1454, 2019) 2019
- A Peculiar Wide Complex Tachycardia 2019
- Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial. 139:366-375. 2019
- Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial. 138:2884-2894. 2018
- New Insights From Recent Large Trials 2018
- Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes and Prior Coronary Artery Bypass Graft (CABG) Surgery: A Sub-Analysis of the LEADER Trial 2018
- Malignancy Type Impacts Coronary Lesion Severity and Location: Multivariable Regression With Concurrent Machine Learning-Backed Case-Control Analysis 2018
- The Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide Improve Cardiovascular and Renal Outcomes Across Baseline Blood Pressure Categories: Analysis of LEADER and SUSTAIN 6 2018
- The Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide Improve Cardiovascular and Renal Outcomes Across Most Body Mass Index Categories in Type 2 Diabetes: Results of the LEADER and SUSTAIN 6 Trials 2018
- The Role of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting Contrast Induced Acute Kidney Injury in Patients Presenting With Acute Coronary Syndrome 2018
- Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure. 138:1923-1934. 2018
- Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease Results of the LEADER Trial 2018
- Interhospital Transfer Before Thrombectomy Is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke). 136:2311-2321. 2017
- Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. 135:2003-2012. 2017
- Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves 2017
- The Failing Heart Relies on Ketone Bodies as a Fuel. 133:698-705. 2016
- Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome. 133:21-30. 2016
- The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial 2015
- Ongoing Evolution of Outcomes Analysis for Pediatric and Congenital Cardiac Catheterization 2015
- The Heart Is Just a Muscle. 131:914-922. 2015
- The Value of Cardiac Magnetic Resonance Imaging in Detection of Sub-Clinical Cellular Rejection 2013
- Surgeon Volume is Associated With Operative Mortality After Congenital Cardiac Surgery 2012
- When the Heart Runs Out of Heartbeats Treatment Options for Refractory End-Stage Heart Failure. 125:2948-2955. 2012
- Weight Loss Decreases High Sensitivity C-Reactive Protein Irrespective of Dietary Composition 2011
- Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. 124:695-U130. 2011
- Automated Vulnerability Testing Accurately Identifies Patients with Inadequate Defibrillation Safety Margin 2010
- Relationship of Intraoperative Cerebral Oxygen Saturation to Neurodevelopmental Outcome and Brain Magnetic Resonance Imaging at 1 Year of Age in Infants Undergoing Biventricular Repair. 122:245-254. 2010
- Report of the Pediatric Heart Network and National Heart, Lung, and Blood Institute Working Group on the Perioperative Management of Congenital Heart Disease. 121:2766-2772. 2010
- Autologous CD34+Cell Therapy for Refractory Angina: 12 Month Results of the Phase II ACT34-CMI Study 2009
- Outcomes After Anatomic Repair for D-Transposition of the Great Arteries With Left Ventricular Outflow Tract Obstruction. 120:S53-S58. 2009
- Pulmonary Valve Replacement in Tetralogy of Fallot Impact on Survival and Ventricular Tachycardia. 119:445-451. 2009
- Association Between Intraoperative and Early Postoperative Glucose Levels and Adverse Outcomes After Complex Congenital Heart Surgery. 118:2235-2242. 2008
- Factors associated with prolonged recovery after the Fontan operation. 118:S171-S176. 2008
- Platelet activation and thrombosis by antibodies against VEGF and CD40 ligand: Extending the mechanism of HIT 2007
- Short term outcomes in heart failure patients, after initiation of guideline based therapies designed to improve performance measures 2007
- Quality improvement initative in management of acute ST-segment elevation myocardial infarction by primary angioplasty in a multiple campus hospital 2006
- Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. 113:1641-1649. 2006
- Arrhythmogenic right ventricular dysplasia - A United States experience. 112:3823-3832. 2005
- Three-year safety and efficacy of the polymer-based paclitaxel-eluting TAXUS stent: The TAXUS-IV trial 2005
- Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. 112:1451-1461. 2005
- Cardiac hemangioma 2005
- Durability of the polymer-based, paclitaxel-eluting TAXUS stent: Two-year results from the TAXUS-IV trial 2004
- Evidence for a role of the CD40/CD40 ligand (CD40L) pathway in primary hemostasis and platelet function 2004
- Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: Results from the TAXUS-IV trial 2004
- Pivotal US study of the Symbiot(TM) III covered stent system in patients with saphenous vein graft disease: 8-month angiographic and clinical results from the Symbiot III trial 2004
- Relation of late loss to target lesion revascularization in the drug-eluting stent era: What is the threshold for acceptable late loss? A TAXUS IV substudy 2004
- Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity - A need to broaden diagnostic criteria. 110:1527-1534. 2004
- One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus - Response 2004
- One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS Stent the TAXUS-IV trial. 109:1942-1947. 2004
- CD40 deficiency is associated with prolonged bleeding time and abnormal clot retraction 2003
- Frequency of heparin-platelet factor 4 antibodies in patients presenting to the emergency department with symptoms of thrombosis 2003
- Functionally active tissue factor is present in platelet-derived microparticles from normal donors 2003
- Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. 105:1285-1290. 2002
- Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart - Prospects for molecular ventricular assistance. 101:408-414. 2000
- Repair of tetralogy of Fallot in neonates and young infants. 1999
- DUETT femoral artery closure device vs manual compression after diagnostic or interventional catheterization: Results of the SEAL trial 1999
- Percutaneous myocardial laser revascularization in patients with class 3-4 angina and lesions at high risk for restenosis - Results of the phase I pilot study as a preamble to a large, randomized trial 1998
- Ventricular and myocardial efficiencies during acute aortic regurgitation in conscious dogs. 1997
- Bleeding risk with platelet inhibition using tirofiban: The RESTORE trial 1996
- Does interventional volume or academic status affect outcome? Insights from the IMPACT-II trial 1996
- A MULTICENTER, RANDOMIZED TRIAL OF CORONARY ANGIOPLASTY VERSUS DIRECTIONAL ATHERECTOMY FOR PATIENTS WITH SAPHENOUS-VEIN BYPASS GRAFT LESIONS. 91:1966-1974. 1995
- COMPARISON OF THE BLEEDING POTENTIAL OF VAMPIRE BAT SALIVARY PLASMINOGEN-ACTIVATOR VERSUS TISSUE-PLASMINOGEN ACTIVATOR IN AN EXPERIMENTAL RABBIT MODEL. 91:1540-1544. 1995
- PROPOSED CRITERIA FOR LEAD-DEPARTMENT LATE POTENTIALS IN SIGNAL-AVERAGED ECG 1994
- EXCIMER-LASER CORONARY ANGIOPLASTY OF AORTO-OSTIAL STENOSES - RESULTS OF THE EXCIMER-LASER CORONARY ANGIOPLASTY (ELCA) REGISTRY IN THE 1ST 200 PATIENTS. 88:2049-2057. 1993
- EFFECTIVE THROMBOLYSIS WITHOUT MARKED PLASMINEMIA AFTER BOLUS INTRAVENOUS ADMINISTRATION OF VAMPIRE BAT SALIVARY PLASMINOGEN-ACTIVATOR IN RABBITS. 84:244-253. 1991
- CLINICAL-EXPERIENCE WITH THE PALMAZ-SCHATZ CORONARY STENT - INITIAL RESULTS OF A MULTICENTER STUDY. 83:148-161. 1991
- THE EFFECT OF AMINO-ACID L-GLUTAMATE ON THE EXTENDED PRESERVATION EXVIVO OF THE HEART FOR TRANSPLANTATION. 76:65-70. 1987
- A NEW TEMPORARY ATRIAL ELECTRODE DESIGNED FOR BLIND PERVENOUS PLACEMENT - RESULTS IN 70 PATIENTS 1981
Research
category
- CARDIAC & CARDIOVASCULAR SYSTEMS Web of Science Category
- PERIPHERAL VASCULAR DISEASE Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 0009-7322
Electronic International Standard Serial Number (EISSN)
- 1524-4539
Other
journal abbreviation
- CIRCULATION
- Circulation